| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |